Clinical Trial Update: Preventive Effect of Pitavastatin on Contrast-Induced Nephropathy in Patients With Renal Dysfunction [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update investigating whether pitavastatin can prevent contrast-induced nephropathy in patients with renal dysfunction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy

Drugs mentioned

• Pitavastatin (Pitavastatin)

Snippet

Sponsor: Gachon University Gil Medical Center | Conditions: Contrast-induced Nephropathy | Phase 4 | Status: UNKNOWN